Search the Newsreel

Arkade Developers Ltd (NSE:ARKADE) (Q1 FY27) Earnings Call Highlights: Robust Pipeline and ...

RRX|Regal Rexnord Corp|Price:172.306|Chg%:-0.594

This article provides a detailed financial overview of Regal Rexnord Corp (RRX), including its stock price, key figures, and recent performance. It highlights the company's stock score, analyst ratings, and technical analysis, showing a "Buy" consensus with a target price significantly above the current …

Telomir Pharmaceuticals (NASDAQ:TELO) Releases Quarterly Earnings Results

Melcor Developments announces second quarter results, declares quarterly dividend of $0.15 per share

Telos (NASDAQ:TLS) Director Derrick Dockery Sells 11,000 Shares of Stock

Telos Director Derrick Dockery recently sold 11,000 shares of the company's stock for $47,740, reducing his direct ownership by 6.13%. This transaction follows Telos's positive quarterly earnings report, where the company beat EPS and revenue estimates, causing its shares to rise by 6.0%. Despite …

DeFi Development Corp. (DFDV) swings to $110.7M loss on Solana strategy

DeFi Development Corp. (DFDV) reported a significant net loss of $110.7 million for the first half of 2026, primarily due to severe losses on its digital asset holdings and derivatives tied to Solana (SOL) financing. Despite a substantial increase in revenue from its Digital …

Jefferies Just Upgraded Five Below Stock. Here's Why.

Jefferies has upgraded Five Below (FIVE) stock, raising its price target to $350 due to anticipated structural improvements and strong comparable sales growth. Analyst Randal Konik projects significant upside for the discount retailer, driven by consistent productivity gains and store network expansion. While the …

Artelo Biosciences Releases Q2 2026 Financial Results

Artelo Biosciences, Inc. reported a net loss of $2.4M and a loss of $0.89 per share for Q2 2026, marking a significant improvement from the $16.8 per-share loss in Q2 2025. The clinical-stage biopharmaceutical company continues to advance its therapeutic pipeline targeting lipid-signaling pathways, …

Artelo Plans Q4 Trial After ART26.12 Matches Naproxen for Pain

Artelo Biosciences reported its Q2 2026 financial results, with a narrowed net loss of $2.4 million and positive pipeline updates. The company plans a Phase 1 multiple ascending dose study for ART26.12 in Q4 2026, which has shown pain relief comparable to naproxen in …

Artelo Biosciences (ARTL) investors disclose 4.8% stake via Intracoastal warrant

Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC have disclosed a 4.8% beneficial ownership stake in Artelo Biosciences (ARTL) through a warrant held by Intracoastal. This ownership amounts to 173,914 shares of common stock, issuable upon the warrant's exercise, and is based …

Five Below Shares Rise After Jefferies Upgrade

Five Below (FIVE) shares rose after Jefferies upgraded the stock from Hold to Buy, increasing its price target from $210 to $350. This positive analyst action highlights renewed confidence in the specialty retailer's prospects. The article also mentions recent company news, including the opening …

Kinetic Development Deepens Stake in MC Mining With US$16 Million Share Subscription and Bridge Loan

Five Below Has No Business Selling a Bow Mirror This Chic for $25

Five Below is selling a new coquette-style floor-length bow mirror for just $25, offering a high-end look at a fraction of the price of similar designer versions, such as one from Pottery Barn Teen. The mirror features a sleek design with a white ribbon-style …

Jefferies upgrades Five Below to buy, sees path to TJX-like re-rating

Investing.com -- Jefferies upgraded Five Below to Buy from Hold and raised its price target to $350 from $210, arguing that investors are underestimating structural improvements at the discount retailer and focusing too heavily on the temporary boost from its popular "squishy" products. The …

Jefferies upgrades Five Below to Buy, raises price target to $350 (FIVE:NASDAQ)

Jefferies has upgraded Five Below (FIVE) to Buy from Hold, significantly increasing its price target to $350 from $210. This upgrade is driven by structural improvements in the business and a more optimistic long-term growth outlook for the discount retailer. Following the announcement, Five …

What's Going On With Genesis Land Development Corp. Stock Thursday?

Artelo Biosciences Provides Business Update and Reports 2026 Second Quarter Financial Results

Artelo Biosciences Clinical and Scientific Progress Across the Pipeline Supports Multiple Upcoming Milestones SOLANA BEACH, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) ("Artelo" or the "Company"), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for …

CDB Financial Leasing Signs RMB1.3 Billion Wind Power Finance Lease

City Developments Limited Reports Earnings Results for the Half Year Ended June 30, 2026

ArcelorMittal remains Morgan Stanley’s preferred way to invest in European reindustrialisation

Morgan Stanley analyst Alain Gabriel reiterates ArcelorMittal as his preferred investment for European reindustrialisation due to its significant European shipment base and spare capacity. He believes that fiscal support and an assertive "Made in Europe" industrial policy will accelerate industrial reshoring, benefiting European steelmakers …

Lodha Developers shares gain 2.20%

Autostreets Development Expects Swing to Loss in H1

Jefferies upgrades Five Below stock rating on structural improvements

Belo Sun Mining Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Parsvnath Developers delays Q1FY27 results amid CIRP

Exelon Corp (EXC) Earnings Forecast: Future EPS & Revenue Growth Estimates

Why is Five Below stock rallying today?

Five Below's stock rallied over 3% in pre-open trading after Jefferies upgraded the specialty value retailer from Hold to Buy, significantly raising its price target to $350 from $210. This upgrade, coupled with Mizuho maintaining its Outperform rating and increasing its price target, signals …

NMDC vs Gujarat Mineral Development Corporation: Share Price, PE and ROE Compared

How Investors May Respond To Exelon (EXC) Balancing Storm Recovery Costs With Steady Utility Earnings

Generation Development Group (ASX:GDG) Reports Record AUD 46.4bn FUM Ahead of FY26 Results

Erdene Resource Development Corp (ERD) Earnings Preview — What to Watch Before the Report

Hong Kong's Hysan Development H1 profit rises 7.4%

Hysan Development Company: Recurring Underlying Profit up 1.7% and Underlying Profit up 7.4% on stable turnover and asset gains

Peloton Stock: Value Stock or Value Trap?

Peloton(NASDAQ: PTON) thrived during and before the pandemic years. Missed Nvidia in 2009? This Rare Signal Is Flashing Again.In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing …

SEC Rejects DeFi Development’s $1B Plan to Acquire Solana, But Vision Remains

The SEC has rejected DeFi Development's $1 billion plan to acquire Solana due to incomplete paperwork and eligibility issues, temporarily halting its ambition to become a major corporate holder of SOL. Despite this setback, the company remains committed to its vision, planning to refile …

How Investors Are Reacting To Peyto Exploration & Development (TSX:PEY) Stronger Year‑Over‑Year Earnings Momentum